(1) The Committee comprises each nominated member and no more than 8 appointed members.
(2) A Committee member must have expertise in at least one of the following fields:
(a) the regulation of scheduled medicines in Australia;
(b) toxicology or pharmacology;
(f) consumer health issues relating to the regulation of therapeutic goods;
(g) industry issues relating to the regulation of therapeutic goods.
(3) Membership of the Committee must, to the extent reasonably
practicable, represent the widest possible range of the fields mentioned in
subregulation (2).